Everything below concerns lyophilized powder. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-07-13. Numbers and descriptions here follow the published literature rather than marketing material.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Derived from C-terminal region of human growth hormone |
| Approximate molecular mass | About 1.8 kDa | Varies with sequence length and counterions |
| Confirmed receptor target | None established | No confirmed growth hormone receptor agonism |
| Reported in vitro activity | Lipolysis stimulation and lipogenesis inhibition | Observed mainly in adipocyte models; human relevance uncertain |
| Regulatory status | Not approved as a drug in major markets | May be treated differently across jurisdictions; not a recognized dietary ingredient in some countries |
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Established uitlanders, including the mining magnates, wanted political, social, and economic control over their lives. These rights included a stable constitution, a fair franchise law, an independent judiciary and a better educational system. The Boers recognised that the more concessions they made to the uitlanders the greater the likelihood—with approximately 30,000 white male Boer voters and potentially 60,000 white male uitlanders—that their independent control of the Transvaal would be lost, and the territory absorbed into the British Empire. The uitlanders resented the taxes levied by the Transvaal government, particularly when this was not spent on Johannesburg or uitlander interests but diverted to projects elsewhere in the Transvaal. For example, as the gold-bearing ore sloped away from the outcrop underground to the south, more and more blasting was necessary to extract it, and mines consumed vast quantities of explosives. A box of dynamite costing five pounds included five shillings tax. Not only was this tax perceived as exorbitant, but British interests were offended when President Paul Kruger gave monopoly rights for the manufacture of the explosive to a non-British branch of the Nobel company, which infuriated Britain. The so-called "dynamite monopoly" became a casus belli. British imperial interests were alarmed when in 1894–95 Kruger proposed building a railway through Portuguese East Africa to Delagoa Bay, bypassing British-controlled ports in Natal and Cape Town and avoiding British tariffs.
=== Protists === A common protist eukaryotic expression system is the slime mold, Dictyostelium discoideum, and is unique as it has a circular plasmid, packaged similarly to chromatin. As a simple eukaryotic haploid organism, it can grow in high concentrations without the expensive conditions of mammalian cell culture, and perform post-translational modifications. The protein itself is expressed in several forms including as membrane attached, secreted, or cell associated, and can glycosylate protein product.
=== Clitoris === Located at the anterior junction of the labia minora is the clitoris, a highly erogenous sexual organ. The visible portions of the clitoris are the glans and frenulum. Typically, the glans is roughly the size and shape of a pea, and can vary in size from about 6 mm to 25 mm (less than an inch). The size can also vary when the clitoris is erect, which happens when two regions of erectile tissue known as the corpora cavernosa (along with the bulbs and crura, which both constitute the root of the clitoris) fill with blood, making the shaft engorged. The glans contains many nerve endings, which makes it highly sensitive. The only known function of the clitoris is to focus on sexual feelings. The clitoral hood is a protective fold of skin and it may partially or completely cover the shaft and glans. The hood may be partially or completely hidden within the pudendal cleft.
It was among the first such works to be published, and was followed by many books by white veterans of the war. The book has been widely cited, with historians and commentators arguing that it clearly illustrated the tactics used by the Rhodesians. It does not mention any of the atrocities committed by the Selous Scouts. Many other books have since been published about the Selous Scouts. These works often glorify the unit. In 2018 The New York Times reported that glorification of the Selous Scouts formed part of online nostalgia for Rhodesia and had been taken up by far-right movements that were sympathetic to the white Rhodesian regime. Items branded with the slogan and insignia of the Selous Scouts were available for sale, and a company called the "Selous Armory" was selling a range of apparel glorifying the Rhodesian military. In 2021, the newly established Ranger Regiment in the British Army adopted a cap badge that was similar in appearance to the Selous Scouts' and may have been based on it. The Telegraph reported that "numerous officers have raised concerns" over the badge. The British Army stated that the badge was "designed around the peregrine falcon" and not the osprey as used by the Rhodesian badge.
== Immunoassay == Today, these antigen-proteins can be genetically manufactured (e.g. transgene E. coli) to produce material for a simple antigen test, which detects the presence of HBV. It is present in the sera of patients with viral hepatitis B (with or without clinical symptoms). Patients who developed antibodies against HBsAg (anti-HBsAg seroconversion) are usually considered non-infectious. HBsAg detection by immunoassay is used in blood screening, to establish a diagnosis of hepatitis B infection in the clinical setting (in combination with other disease markers) and to monitor antiviral treatment. In histopathology, the presence of HBsAg is more commonly demonstrated by the use of the Shikata orcein technique, which uses a natural dye to bind to the antigen in infected liver cells. Positive HBsAg tests can be due to recent vaccination against Hepatitis B virus but this positivity is unlikely to persist beyond 14 days post-vaccination.
Sources: en.wikipedia.org
By the abdication of his uncle Ferdinand and the renunciation of his mild-mannered father, Franz Karl, Franz Joseph succeeded as Emperor of Austria at Olmütz on 2 December 1848. This was the first time at which he became known by his first and second given names together. The name "Franz Joseph" was chosen to bring back memories of the new Emperor's great-granduncle, Emperor Joseph II (Holy Roman Emperor from 1765 to 1790), remembered as a modernising reformer. Under the guidance of the new prime minister, Prince Felix of Schwarzenberg, the new emperor initially pursued a cautious course, granting a constitution in March 1849. At the same time, a military campaign was deemed necessary against the Hungarians, who had rebelled against Habsburg central authority in the name of their ancient constitution. Franz Joseph also almost immediately faced a renewal of the fighting in Italy, with King Charles Albert of Sardinia taking advantage of setbacks in Hungary to resume the war in March 1849.
==== MeSH D12.776.964.970.600 – nucleocapsid proteins ==== MeSH D12.776.964.970.600.550 – capsid proteins MeSH D12.776.964.970.600.850 – viral core proteins MeSH D12.776.964.970.600.850.350 – gene products, gag MeSH D12.776.964.970.600.850.350.325 – fusion proteins, gag-pol MeSH D12.776.964.970.600.850.350.400 – hiv core protein p24 MeSH D12.776.964.970.600.850.375 – gene products, pol (gene) MeSH D12.776.964.970.600.850.375.325 – fusion proteins, gag-pol MeSH D12.776.964.970.600.850.375.335 – hiv integrase MeSH D12.776.964.970.600.850.375.340 – HIV protease MeSH D12.776.964.970.600.850.375.750 – RNA-directed DNA polymerase MeSH D12.776.964.970.600.850.375.750.375 – hiv-1 reverse transcriptase
== External links == http://pathmicro.med.sc.edu/mayer/antibiot.htm https://web.archive.org/web/20110227235620/http://www.molgen.mpg.de/~ag_ribo/ag_franceschi/franceschi-projects-50S-antibiotics.html https://web.archive.org/web/20080206051722/http://www.riboworld.com/antib/50santib-eng.shtml 23S+Ribosomal+RNA at the U.S. National Library of Medicine Medical Subject Headings (MeSH) 5S+Ribosomal+RNA at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
While American slaves in the Antebellum South were sold for around $40,000 (in inflation adjusted dollars), a slave nowadays can be bought for just $90, making replacement more economical than providing long-term care. Slavery is a multibillion-dollar industry with estimates of up to $35 billion generated annually.
== Environment == Dumping plastic waste: Thailand ranked sixth of 192 nations with ocean shorelines (1=worst, 192=best). Based on 2010 data, Thailand is estimated to have contributed 1.03 million tonnes of plastic waste to the ocean. The 10 biggest marine polluters (by millions of tonnes of plastic waste dumped in the ocean each year) are: China 8.8; Indonesia 3.2; The Philippines 1.9; Vietnam 1.8; Sri Lanka 1.6; Thailand 1.0; Egypt 1.0; Nigeria 0.9; Malaysia 0.9; and Bangladesh 0.8 Environmental Performance Index 2016: Thailand was ranked 91 of 180 nations (1=best, 180=worst) for its performance on environmental issues. Other ASEAN nations were ranked: Singapore, 14; Malaysia, 63; Philippines, 66; Brunei, 98; Indonesia, 107; Vietnam, 131; Cambodia, 146; Laos, 148; and Myanmmar, 153. Environmental Sustainability Index 2005: Ranked 73 of 146 countries. Fish species, threatened: Of 215 nations, Thailand ranked 12 (1=worst, 215=best) in fish species at risk (96 species) in 2014. ASEAN member-states ranked from number five (Indonesia) to 175 (Brunei). Mammal species, threatened: Of 214 countries studied, Thailand ranks ninth (1=worst, 214=best) in the world in the number of mammal species (55 species) under threat. ASEAN nations fared poorly in this study: Indonesia was number one on the world list with 184 species under threat. The remaining ASEAN nations were ranked: Malaysia, 7; Vietnam, 12; Myanmar, 14; Laos, 15; The Philippines, 19; Cambodia, 20; Brunei, 25; Singapore, 93, of 214 countries.
Sources: en.wikipedia.org
AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.
It is not approved as a prescription drug in the United States or the European Union for any indication. Regulatory status can differ by country, and it is often sold as a research chemical or in unapproved products. Such products are not equivalent to an approved medicine.
In the studies reported so far, AOD9604 does not appear to act through the growth hormone receptor and has not shown the typical IGF-1 increase caused by full-length hGH. Human data are limited, so this remains an area of uncertainty. It should not be assumed to have the same effects as hGH.
No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.